Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 From triazines and triazenes to temozolomide.

× No keyword cloud information.

15 in total

Review 1. Glioblastoma vs temozolomide: can the red queen race be won?

Authors: Anjali Arora; Kumaravel Somasundaram
Journal: Cancer Biol Ther Date: 2019-05-08 Impact factor: 4.742

Review 2. Phenotypic screening in cancer drug discovery - past, present and future.

Authors: John G Moffat; Joachim Rudolph; David Bailey
Journal: Nat Rev Drug Discov Date: 2014-07-18 Impact factor: 84.694

3. Aberrant Kynurenine Signaling Modulates DNA Replication Stress Factors and Promotes Genomic Instability in Gliomas.

Authors: April C L Bostian; Robert L Eoff
Journal: Chem Res Toxicol Date: 2016-08-15 Impact factor: 3.739

4. Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas.

Authors: Alexander M Spence; Richard A Peterson; Jeffrey D Scharnhorst; Daniel L Silbergeld; Robert C Rostomily
Journal: J Neurooncol Date: 2004-10 Impact factor: 4.130

Review 5. Novel oral chemotherapy agents.

Authors: M E Royce; P M Hoff; R Pazdur
Journal: Curr Oncol Rep Date: 2000-01 Impact factor: 5.075

Review 6. New agents in the treatment of primary brain tumors.

Authors: S A Taylor
Journal: J Neurooncol Date: 1994 Impact factor: 4.130

7. Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.

Authors: Michael D Prados; W K Alfred Yung; Howard A Fine; Harry S Greenberg; Larry Junck; Susan M Chang; M Kelly Nicholas; H Ian Robins; Minesh P Mehta; Karen L Fink; Kurt A Jaeckle; John Kuhn; Kenneth R Hess; S Clifford Schold
Journal: Neuro Oncol Date: 2004-01 Impact factor: 12.300

8. Advances in the management of glioblastoma: the role of temozolomide and MGMT testing.

Authors: Reena P Thomas; Lawrence Recht; Seema Nagpal
Journal: Clin Pharmacol Date: 2012-12-27

9. Prospective study evaluating the radiosensitizing effect of reduced doses of temozolomide in the treatment of Egyptian patients with glioblastoma multiforme.

Authors: May Gaber; Hanan Selim; Tamer El-Nahas
Journal: Cancer Manag Res Date: 2013-10-08 Impact factor: 3.989

10. Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma.

Authors: Michelle S Boyar; Mary Hesdorffer; Mary Louise Keohan; Zhezhen Jin; Robert N Taub
Journal: Sarcoma Date: 2008-11-16